RMD, CSL, COH, VRT: How are these healthcare stocks faring at ASX?

Image Source: © Richelle538 | Megapixl.com

Highlights:

  • The S&P/ASX 200 Health Care (Sector) XHJ was up 0.604% at 38513 points at 12:27 PM AEST today. 
  • The Healthcare sector comprises several industries such as pharmaceuticals, hospitals, medical equipment & devices, and health insurers. 
  • The shares of four ASX-listed healthcare stocks, ResMed Inc, CSL Ltd., Cochlear Limited, and Virtus Health Ltd, have been in the news recently.   

 

ASX200 was up 0.108% at 6530.900 points at 11:57 AM AEST today (June 22) after losing nearly 1.21% over the last five days and 11.18% over the last 52 weeks.   

The S&P/ASX 200 Health Care (Sector) XHJ was up 0.604% at 38513 points at 12:27 PM AEST. As of 22 June 2022, its year-to-date and one-year returns stand at nearly -16% and -15%, respectively. The healthcare industry has always been very important, and it has been in focus after the Coronavirus pandemic.  

The healthcare sector comprises several different industries, including pharmaceuticals, hospitals, medical equipment & devices, and health insurers.  

In this article we will discuss four ASX-listed healthcare stocks which have been in focus recently. These four stocks include ResMed Inc (ASX:RMD), CSL Ltd. (ASX:CSL), Cochlear Limited (ASX:COH), and Virtus Health Ltd (ASX:VRT).    

Also watch: 

 

ResMed Inc (ASX:RMD) 

The share price of medical device company ResMed Inc traded 0.720% lower at AU$28.940 per share on ASX at 1:08 PM AEST today. The company has a market capitalisation of AU$42.67 billion. The company provides cloud-connected medical devices that transform care for people affected with sleep apnea, COPD and other chronic diseases. ResMed falls in the Health Care Equipment & Services industry group. In the last one year, ResMed Inc shares have fallen nearly 9.59%, while the stock is down almost 20.01% year-to-date (YTD).   

Read More: QX Resources (ASX:QXR) recommences phase two trenching program at Big Red, shares zoom 9% 

Image Source: © Adonis1969 | Megapixl.com 

 

CSL Ltd. (ASX:CSL 

CSL shares traded approx. 0.249% higher at AU$260.66 per share on ASX at 1:13 PM AEST today (June 22). The company has a market capitalisation of AU$125.24 billion. CSL Ltd. falls in the Pharmaceuticals, Biotechnology & Life Sciences industry group. In the last one year, CSL shares have fallen nearly 13.26%, while the stock is down almost 11.94% on YTD. The biotechnology company focuses on rare and serious diseases and influenza vaccines. CSL is also a leading provider of in-licensed vaccines.  

Cochlear Limited (ASX:COH 

Cochlear shares were spotted trading 0.616% higher at AU$191.725 per share on ASX at 1:25 PM AEST today. With a market capitalisation of AU$12.53 billion, the company falls in the Health Care Equipment & Services industry group. The share price of Cochlear Limited has fallen nearly 22.33% in the last one year; while the stock is down almost 13.93% YTD.   

Virtus Health Ltd (ASX:VRT 

The shares of Virtus Health Ltd were spotted trading 0.383% lower at AU$7.800 per share on ASX at 1:40 PM AEST today. The AU$682.10 million company falls in the Health Care Equipment & Services industry category. In the last one year, Virtus Health shares have gained almost 24%, while the stock is up nearly 15.56% on YTD.   

The company is expected to pay a fully franked interim dividend of AU$0.300 per share on 1 July 2022. Earlier this month, Virtus declared that the BGH Bidders had increased the consideration payable to Virtus shareholders under the BGH Offer to $8.155 per Virtus share.   


 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and